The exosomal transfer of miR-567 was recently reported to reverse trastuzumab resistance in BC via Autophagy related 5 (ATG5) inhibition; thereby, its therapeutic addition may considerably improve and enhance patients’ responsiveness to this drug [106]. The gene discussed is ATG5; the disease is breast cancer.